e-learning
resources
Glasgow 2004
Wednesday 08.09.2004
Molecular biology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Tailored therapy for non-small cell lung cancer – it is difficult to get enough good quality mRNA from bronchoscopic biopsies
K. Laule-Kilian, L. Bubendorf, M. Pless, M. Mirlacher, M. Tamm, M. H. Brutsche (Basle, Switzerland)
Source:
Annual Congress 2004 - Molecular biology
Session:
Molecular biology
Session type:
Oral Presentation
Number:
4323
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Laule-Kilian, L. Bubendorf, M. Pless, M. Mirlacher, M. Tamm, M. H. Brutsche (Basle, Switzerland). Tailored therapy for non-small cell lung cancer – it is difficult to get enough good quality mRNA from bronchoscopic biopsies. Eur Respir J 2004; 24: Suppl. 48, 4323
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Lung function and quality of life after surgical treatment of non-small cell lung cancer – preliminary results
Source: Annual Congress 2008 - Treatment of thoracic tumours
Year: 2008
Bronchoscopic treatment of inoperable nonsmall cell lung cancer
Source: Eur Respir Rev, 29 (158) 200035; 10.1183/16000617.0035-2020
Year: 2020
Bronchoscopic intratumoural therapies for non-small cell lung cancer
Source: Eur Respir Rev, 29 (156) 200028; 10.1183/16000617.0028-2020
Year: 2020
The evaluation of surgical results in pT0-pT1 non-small cell lung carcinoma after induction therapy
Source: Annual Congress 2011 - General thoracic surgery II
Year: 2011
Improving standards in flexible bronchoscopy for lung cancer
Source: Eur Respir J 2011; 37: 895-901
Year: 2011
Possibilities of palliative combined therapy for extensive nonsmall cells lung cancer
Source: Eur Respir J 2001; 18: Suppl. 33, 378s
Year: 2001
The method of individualisation of treatment and prognosis for advanced non-small cell lung cancer
Source: Annual Congress 2010 - Prognostic factors for lung cancer
Year: 2010
Long-term results of surgically treated non-small cell lung cancer patients depending on the protocol of preoperative N-staging
Source: Annual Congress 2011 - General thoracic surgery II
Year: 2011
Completion pneumectomy is a safe procedure for non-small cell lung cancer
Source: International Congress 2019 – Thoracic oncology: Treatment, diagnostic options and biology
Year: 2019
Utilisation of biomarker testing to guide therapy in non-small cell lung cancer in a regional lung cancer service
Source: International Congress 2018 – Genetics in chronic pulmonary diseases
Year: 2018
Customising chemotherapy in advanced nonsmall cell lung cancer: daily practice and perspectives
Source: Eur Respir Rev 2011; 20: 45-52
Year: 2011
Relevance of an extensive follow-up after surgery for nonsmall cell lung cancer
Source: Eur Respir J 2013; 42: 1357-1364
Year: 2013
Early recurrence in complete resected non-small cell lung cancer patients
Source: International Congress 2017 – Lung cancer: important scientific reports from endoscopists and thoracic surgeons
Year: 2017
The comparison of the findings of preoperative PET-CT and surgical pathology in patients with non-small cell lung cancer those with and without induction therapy
Source: Annual Congress 2011 - General thoracic surgery II
Year: 2011
Salvage surgery in patients with locally advanced non-small cell lung cancer – outcomes and longtime results
Source: Virtual Congress 2021 – Therapy of lung cancer
Year: 2021
Should there be a specific management for large cell neuroendocrine carcinoma?
Source: Annual Congress 2005 - Neuroendocrine tumours of the lung
Year: 2005
Surgical and nonsurgical approaches to small-size nonsmall cell lung cancer
Source: Eur Respir J 2014; 44: 483-494
Year: 2014
Surgical treatment of nonsmall cell lung cancer
Source: ISSN=1025-448x, ISBN=1-904097-18-9, page=170
Year: 2001
Long-term survival after surgical resection for non-small cell lung cancer
Source: International Congress 2017 – Lung cancer: important scientific reports from endoscopists and thoracic surgeons
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept